Serial Number
85243484
Owner
The International Genomics ConsortiumAttorney
Howard I. SobelmanFirst Use Date
Sep 30, 2003
Filing Date
Feb 16, 2011
INTERNATIONAL GENOMICS CONSORTIUM Trademark
Serial Number: 85243484 • Registration: 4066194
Trademark Classes
Class 39 - Transportation & Storage
Transport; packaging and storage of goods; travel arrangement
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 35 - Advertising & Business
Advertising; business management; business administration; office functions
Owner Contact Info
400 North Fifth Street Suite 1650
Phoenix, AZ 85004
Entity Type: 99
Legal Representation
Trademark Details
Filing Date
February 16, 2011
Registration Date
December 6, 2011
First Use Anywhere
September 30, 2003
First Use in Commerce
September 30, 2003
Published for Opposition
September 20, 2011
Goods & Services
Distributing clinical specimens, such as blood and tissue samples, to research entities for correlative studies
medical research support services, namely, recruitment of patients and subjects for various studies
Research and scientific analysis, namely, molecular and genomic sequencing and analysis comprising genomic research, bioinformatics, and diagnostic technologies to analyze complex genetic diseases; collection, processing and storage of blood and tissue samples and associated genomic data and clinical outcome information, and utilizing standardized protocols linked to a centralized molecular profiling laboratory to perform such analysis. Establishing and augmenting national and international standards for consent, tissue collection, clinical annotation, molecular analysis and representation of data; providing online medical and research information relating to biological samples obtained under standardized conditions, along with associated gene expression data and long-term patient clinical outcome data to accelerate the discovery of targets for therapy, prognosis and diagnosis; providing a research platform to allow users to facilitate transitioning of genomic discoveries from the bench to a patient's bedside to improve patient care; pharmaceutical drug development services, medical and scientific research consultation services in the field of clinical trials; medical research, collecting and analyzing clinical samples, analyzing clinical data, and DNA sequencing all in the fields of genomics, biomedicine, biosciences, and bioinformatics; computer software development services in the fields of genomics, biomedicine, biosciences, and bioinformatics
